Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Muscarinic Acetylcholine Receptor M2 (M2 mAChR) is a G protein-coupled receptor that primarily couples to Gi/o proteins. Upon activation by acetylcholine, it inhibits adenylyl cyclase activity, reducing cAMP levels, and activates G protein-coupled inwardly rectifying potassium channels, particularly in the heart, leading to hyperpolarization and decreased excitability. It plays a key role in regulating cardiac rate, airway smooth muscle tone, and has been implicated in central nervous system functions. The high degree of conservation at the orthosteric binding pocket complicates the development of highly subtype-selective ligands.
Agonists bind to the orthosteric site, activating Gi/o proteins, which inhibits adenylyl cyclase and activates G protein-coupled inwardly rectifying potassium channels. Antagonists block the orthosteric site, preventing acetylcholine binding and downstream signaling.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Muscarinic Acetylcholine Receptor M2 (M2 mAChR).